Cited by 112Artificial Intelligence in Healthcare and EducationStatistical Methods in EpidemiologyArtificial Intelligence in Healthcare

Evaluation of performance measures in predictive artificial intelligence models to support medical decisions: overview and guidance

Open access
Van Calster, Ben, Collins, Gary S, Vickers, Andrew J, Wynants, Laure, Kerr, Kathleen F, Barreñada, Lasai, Varoquaux, Gael, Singh, Karandeep +6 more·2025·The Lancet Digital Health

Abstract

Numerous measures have been proposed to illustrate the performance of predictive artificial intelligence (AI) models. Selecting appropriate performance measures is essential for predictive AI models intended for use in medical practice. Poorly performing models are misleading and may lead to wrong clinical decisions that can be detrimental to patients and increase financial costs. In this Viewpoint, we assess the merits of classic and contemporary performance measures when validating predictive AI models for medical practice, focusing on models that estimate probabilities for a binary outcome. We discuss 32 performance measures covering five performance domains (discrimination, calibration, overall performance, classification, and clinical utility) along with corresponding graphical assessments. The first four domains address statistical performance, whereas the fifth domain covers decision-analytical performance. We discuss two key characteristics when selecting a performance measure and explain why these characteristics are important: (1) whether the measure's expected value is optimised when calculated using the correct probabilities (ie, whether it is a proper measure) and (2) whether the measure solely reflects statistical performance or decision-analytical performance by properly accounting for misclassification costs. 17 measures showed both characteristics, 14 showed one, and one (F1 score) showed neither. All classification measures were improper for clinically relevant decision thresholds other than when the threshold was 0·5 or equal to the true prevalence. We illustrate these measures and characteristics using the ADNEX model which predicts the probability of malignancy in women with an ovarian tumour. We recommend the following measures and plots as essential to report: area under the receiver operating characteristic curve, calibration plot, a clinical utility measure such as net benefit with decision curve analysis, and a plot showing probability distributions by outcome category.

AI snapshot

Written from the paper’s full text.

TL;DR

This Viewpoint evaluates 32 performance measures for predictive AI models with binary outcomes across five domains and argues that measures should be proper and clearly focused on either statistical or decision-analytical performance. It recommends reporting AUROC, a calibration plot, a clinical utility measure such as net benefit with decision curve analysis, and a plot of probability distributions by outcome category.

Key findings

  • Of 32 measures, 17 showed both key characteristics (properness and clear statistical or decision-analytical focus), 14 showed one, and F1 showed neither; all classification measures were improper at clinically relevant decision thresholds other than when the threshold was 0·5 or equal to the true prevalence.
  • In the ADNEX external validation case study (n=894; 434 malignant; prevalence 49%), AUROC was 0·911 (95% CI 0·894–0·927); the O:E ratio was 1·228 (1·171–1·288) before recalibration and 1·000 (0·955–1·046) after; net benefit at t=0·1 was 0·443 (0·411–0·475) before and 0·444 (0·411–0·478) after recalibration.
  • Recalibration improved all strictly proper measures and left semi-proper measures improved or unchanged, while most improper classification summary measures worsened (e.g., classification accuracy 0·794 to 0·691; F1 0·818 to 0·756; MCC 0·625 to 0·480).
  • The recommended core set is AUROC, a smoothed calibration plot, a clinical utility measure such as net benefit with decision curve analysis, and a figure showing probability distributions for each outcome category.

Methods

  • Viewpoint assessing classic and contemporary performance measures for predictive AI models that estimate probabilities for a binary outcome; 32 measures were classified into five domains: discrimination, calibration, overall performance, classification, and clinical utility.
  • Illustrative case study: external validation of the ADNEX model for predicting malignancy in women with an ovarian tumour, using TransIOTA data from 894 women (434 malignant, prevalence 49%) recruited between 2015 and 2019 in one secondary and five tertiary care centres in four countries.
  • All discussed measures were calculated with 95% CIs using the percentile bootstrap method on 1000 bootstrap samples, before and after logistic recalibration; code and risk estimates/outcomes are available in a GitHub repository, while the complete dataset cannot be publicly shared owing to privacy considerations.

Limitations

  • Stated: the Viewpoint focused only on performance measures for binary outcomes, did not address counterfactual prediction, could not discuss all measures, and did not directly discuss model comparisons in depth.
  • Stated: calibration and performance-measure research is ongoing, including work on strong calibration, quantifying miscalibration, and uncertainty.
  • Evident: as a Viewpoint rather than a systematic review, the recommendations are based on selected measures and a single case study (ADNEX external validation), so generalizability to other outcomes and settings is not empirically tested here.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1016/j.landig.2025.100916

Cites

90 of 90 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

0 of 91 cited sources checked · 0 supported · 0 flagged

  • Findingnone given
    § Evaluation of performance measures in predictive artificial intelligence models to support medical decisions: overview and guidance · p. 1

    All classification measures were improper for clinically relevant decision thresholds other than when the threshold was 0.5 or equal to the true prevalence.

    “All classification measures were improper for clinically relevant decision thresholds other than when the threshold was 0 ⋅ 5 or equal to the true prevalence.”
    Quote in the paperSubstantial claim
  • Findingown data
    § Calibration · p. 6

    The ADNEX calibration plots lie mostly above the diagonal.

    “The plots lie mostly above the diagonal”
    Quote in the paperNot a substantial claim
  • Findingown data
    § Calibration · p. 5

    ADNEX had an O:E ratio of 1.23 (95% CI 1.17-1.29), indicating that 23% more events were observed than expected based on the model.

    “ADNEX had an O:E ratio of 1 ⋅ 23 (95% CI 1 ⋅ 17-1 ⋅ 29), indicating that 23% more events were observed than expected based on the model (table 1).”
    Quote in the paperNot a substantial claim
  • Findingown data
    § Calibration · p. 6

    In the ADNEX case study, the model had a calibration slope of 0.93 (95% CI 0.83-1.05).

    “In our case study, the ADNEX model had a calibration slope of 0 ⋅ 93 (95% CI 0 ⋅ 83-1 ⋅ 05)”
    Quote in the paperNot a substantial claim
  • Findingown data
    § Results after recalibration · p. 8

    The improper summary measures for classification (except diagnostic odds ratio) worsened remarkably after recalibration.

    “The improper summary measures for classification (except diagnostic odds ratio) worsened remarkably.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim. 62
  • May combine two claims. 47
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Findingnone given
    § Discrimination · p. 5

    The ADNEX model had an AUROC of 0.91 (95% CI 0.89-0.93) and an AUPRC of 0.89 (95% CI 0.86-0.91).

    “The ADNEX model had an AUROC of 0 ⋅ 91 (95% CI 0 ⋅ 89-0 ⋅ 93) and an AUPRC of 0 ⋅ 89 (95% CI 0 ⋅ 86-0 ⋅ 91).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data
    § Calibration · p. 5

    The calibration intercept of the ADNEX model was 0.81 (95% CI 0.62-1.01), suggesting underestimation of probabilities on average (intercept > 0).

    “The calibration intercept of the ADNEX model was 0 ⋅ 81 (95% CI 0 ⋅ 62-1 ⋅ 01), suggesting underestimation of probabilities on average (intercept > 0).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingnone given
    § Discrimination · p. 5

    Ignoring sensitivity values below 0.8, pAUROC was 0.14 (95% CI 0.13-0.15).

    “Ignoring sensitivity values below 0 ⋅ 8, pAUROC was 0 ⋅ 14 (95% CI 0 ⋅ 13-0 ⋅ 15).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Findingnone given
    § Calibration · p. 6

    Five of six participating centres in the validation study were tertiary care centres, resulting in a high prevalence of malignancy (49%).

    “A probable reason is that fi ve of six participating centres in the validation study were tertiary care centres, resulting in a high prevalence of malignancy (49%).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingnone given
    § Evaluation of performance measures in predictive artificial intelligence models to support medical decisions: overview and guidance · p. 1

    17 measures showed both characteristics, 14 showed one, and one (F1 score) showed neither.

    “17 measures showed both characteristics, 14 showed one, and one (F1 score) showed neither.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data
    § Results after recalibration · p. 8

    Some partial classification measures improved (sensitivity and NPV), whereas others worsened (specificity and PPV) after recalibration.

    “Some partial classification measures improved (sensitivity and NPV), whereas others worsened (specificity and PPV).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data
    § Classification measures · p. 7

    At a threshold of 10%, the ADNEX model showed a classification accuracy of 0.79 (95% CI 0.77-0.82), F1 score of 0.82 (0.79-0.84), and MCC of 0.63 (0.58-0.67).

    “At a threshold of 10%, the ADNEX model showed a classification accuracy of 0 ⋅ 79 (95% CI 0 ⋅ 77-0 ⋅ 82), F1 score of 0 ⋅ 82 (0 ⋅ 79-0 ⋅ 84), and MCC of 0 ⋅ 63 (0 ⋅ 58-0 ⋅ 67) (table 1).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingcitation
    § Classification measures · p. 6

    At the commonly recommended threshold of 10%, the ADNEX model classified 578 patients as high risk, of whom 414 had a malignant tumour (true positive) and 164 had a benign tumour (false positive); the remaining 316 patients were classified as low risk, of whom 296 had a benign tumour (true negative) and 20 had a malignant tumour (false negative).

    “At the commonly recommended threshold of 10% in our case study, 23 ADNEX classified 578 patients as high risk, of whom 414 had a malignant tumour (true positive) and 164 had a benign tumour (false positive). The remaining 316 patients were classified as low risk, of whom 296 had a benign tumour (true negative) and 20 had a malignant tumour (false negative).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [23] Timmerman, 2021, ESGO/ISUOG/IOTA/ESGE consensus statement on preoperative diagnosis of ovarian tumors, Ultrasound Obstet Gynecol source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingcitation
    § Discussion · p. 10

    Calibration is an active area of research focusing on aspects such as strong calibration, quantifying the degree of miscalibration, and uncertainty.

    “For example, calibration is an active area of research focusing on aspects such as strong calibration, quantifying the degree of miscalibration, and uncertainty.”
    Quote in the paperNot a substantial claim0 of 4 sources checked
    • cites [62] Arrieta-Ibarra, 2022, Metrics of calibration for probabilistic predictions, J Mach Learn Res

      Not checked in the free run.

    • cites [113] Perez-Lebel, 2022, Beyond calibration: estimating the grouping loss of modern neural networks, arXiv

      Not checked in the free run.

    • cites [114] Kompa, 2021, Second opinion needed: communicating uncertainty in medical machine learning, NPJ Digit Med source

      Not checked in the free run.

    • cites [115] Riley, 2023, Stability of clinical prediction models developed using statistical or machine learning methods, Biom J source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S2 (checkable), S4 (based). May combine two claims.

    Premisenone given
    § Panel: Defining a decision threshold · p. 3

    If misclassification costs influence a performance measure in an implicit or ad hoc way, the measure neither assesses statistical performance nor adequately evaluates the quality of decisions for clinical practice.

    “If misclassification costs influence a performance measure in an implicit or ad hoc way, the measure neither assesses statistical performance nor adequately evaluates the quality of decisions for clinical practice.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Premisereasoning
    § Department of Development · p. 2

    Discrimination reflects relative performance; it does not matter how high or low the estimated probabilities are, only whether they allow discrimination between individuals with versus without the event.

    “Discrimination reflects relative performance; ie, it does not matter how high or low the estimated probabilities are, only whether they allow to discriminate between individuals with versus without the event.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Premisenone given
    § Department of Development · p. 2

    Classification performance is influenced by discrimination and calibration performance.

    “Classification performance is influenced by discrimination and calibration performance.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S2 (checkable). May combine two claims.

    Premisereasoning
    § Panel: Defining a decision threshold · p. 3

    Using statistical arguments to set a decision threshold is inconsistent with decision theory and detached from practical use by clinicians.

    “Using statistical arguments to set a decision threshold is inconsistent with decision theory and detached from practical use by clinicians.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: The primary aim of most predictive AI models in medical practice is to support subsequent decision making.
  • May combine two claims.

    Premisereasoning
    § Clear focus on statistical or decision-analytical evaluation · p. 2

    Statistical performance measures are essential for model evaluation but cannot be used to find out whether a model should be used in practice.

    “Statistical performance measures are essential for model evaluation but cannot be used to fi nd out whether a model should be used in practice: it is not appropriate to cite, for example, good discrimination and calibration or conclude that a model can be used to aid decisions about ovarian surgery.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Premisereasoning
    § Department of Development · p. 2

    Clinical utility goes one step further by explicitly incorporating misclassification costs when evaluating classifications of individuals into low-risk and high-risk groups.

    “The fi fth domain, clinical utility, goes one step further by explicitly incorporating misclassification costs when evaluating classifications of individuals into low-risk and high-risk groups.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation
    § Department of Development · p. 1

    The first three performance domains evaluate performance based on probability estimates.

    “Among these domains, the fi rst three evaluate performance based on probability estimates (Appendix p 2).”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Premisereasoning
    § Properness · p. 2

    When an incorrect model can have a better expected value than the correct model, the measure is termed improper and cannot be trusted.

    “When an incorrect model can have a better expected value than the correct model, the measure is termed improper and cannot be trusted.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Premisereasoning
    § Properness · p. 2

    The importance of properness is that a proper measure cannot be fooled: in expectation, the correct model cannot be outperformed by an incorrect one.

    “The importance of properness is that a proper measure cannot be fooled: in expectation, the correct model cannot be outperformed by an incorrect one.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisenone given
    § Department of Development · p. 2

    The fourth and fifth performance domains require a threshold on the estimated risk of the event to classify individuals into two mutually exclusive groups.

    “The fourth and fi fth performance domains require a threshold on the estimated risk of the event to classify individuals into two mutually exclusive groups: low-risk (estimated risk below the threshold) and high-risk (estimated risk equal to or above the threshold) groups.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable), S4 (based). May combine two claims.

    Premisenone given
    § Key characteristics of an informative performance measure · p. 2

    Measures that do not possess the first characteristic cannot be trusted, whereas measures not possessing the second are equivocal.

    “Measures that do not possess the fi rst characteristic cannot be trusted, whereas measures not possessing the second are equivocal.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation
    § Introduction · p. 1

    Poorly performing predictive AI models intended for medical practice are misleading and may lead to wrong clinical decisions that can be detrimental to patients and increase financial costs.

    “poorly performing models might lead to wrong clinical decisions that can be detrimental to patients and increase fi nancial costs. 5”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [5] Kamran, 2024, Evaluation of sepsis prediction models before onset of treatment, NEJM AI source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisereasoning
    § Department of Development · p. 2

    Calibration reflects absolute performance by evaluating whether estimates are too high or too low.

    “Calibration reflects absolute performance by evaluating whether estimates are too high or too low.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisereasoning
    § Department of Development · p. 2

    Models can have good discrimination but poor calibration, and vice versa.

    “Models can therefore have good discrimination but poor calibration, and vice versa.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Premisecitation
    § Discrimination · p. 4

    The definition of discrimination implies that discrimination measures should rely only on the ranks of the estimated probabilities in the dataset.

    “The definition of discrimination implies that discrimination measures should rely only on the ranks of the estimated probabilities in the dataset. 36”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [36] Berrar, 2012, Caveats and pitfalls of ROC analysis in clinical microarray research (and how to avoid them), Brief Bioinform source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Premisenone given
    § Calibration · p. 5

    Research on the quantification of a fourth level, strong calibration, is ongoing.

    “Research on the quantification of a fourth level, strong calibration, is ongoing.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Premisecitation
    § Panel: Defining a decision threshold · p. 3

    A decision threshold of 0.1 (10%) for the probability of malignancy is often recommended.

    “A decision threshold of 0 ⋅ 1 (10%) for the probability of malignancy is often recommended. 23”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [23] Timmerman, 2021, ESGO/ISUOG/IOTA/ESGE consensus statement on preoperative diagnosis of ovarian tumors, Ultrasound Obstet Gynecol source

      Not checked in the free run.

    • Rests on an assumption: The primary aim of most predictive AI models in medical practice is to support subsequent decision making.
  • Classified as probably not a substantial claim. May combine two claims.

    Premisenone given
    § Discrimination · p. 5

    Discrimination measures are not meant to reflect differential misclassification costs, and class imbalance should not be conflated with misclassification costs or medical relevance.

    “Discrimination measures are not meant to reflect differential misclassification costs, and class imbalance should not be conflated with misclassification costs or medical relevance.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation
    § Case study: external validation of a diagnostic model for ovarian cancer · p. 3

    ADNEX was developed on data from 5909 individuals recruited between 1999 and 2012 in 24 secondary and tertiary care centres from 10 countries.

    “ADNEX was developed on the data from 5909 individuals recruited between 1999 and 2012 in 24 secondary and tertiary care centres from 10 countries (Italy, Belgium, Sweden, Czech Republic, Poland, France, United Kingdom, China, Spain, and Canada).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [31] Van Calster, 2014, Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study, BMJ source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation
    § Case study: external validation of a diagnostic model for ovarian cancer · p. 3

    ADNEX can inform decisions regarding type of surgery (advanced vs conservative) for patients examined at an oncology centre or regarding referral to an oncology centre for patients examined elsewhere.

    “The model can inform decisions regarding the type of surgery (advanced vs conservative) for patients examined at an oncology centre or regarding referral to an oncology centre for patients examined elsewhere. 32”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [32] Landolfo, 2024, Comparison of the ADNEX and ROMA risk prediction models for the diagnosis of ovarian cancer: a multicentre external validation in patients who underwent surgery, Br J Cancer source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation
    § Calibration · p. 6

    Estimated probabilities with too much spread are on average too close to 0 and 1 (calibration slope < 1), whereas estimated probabilities with too little spread are on average too close to the prevalence (calibration slope > 1).

    “Estimated probabilities with too much spread are on average too close to 0 and 1 (slope &lt; 1), whereas estimated probabilities with too little spread are on average too close to the prevalence (slope &gt; 1).”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites [52] Van Calster, 2016, A calibration hierarchy for risk models was defined: from utopia to empirical data, J Clin Epidemiol source

      Not checked in the free run.

    • cites [53] Stevens, 2020, Validation of clinical prediction models: what does the “calibration slope” really measure?, J Clin Epidemiol source

      Not checked in the free run.

  • May combine two claims.

    Interpretationreasoning
    § Case study: external validation of a diagnostic model for ovarian cancer · p. 3

    Logistic recalibration is a rank-preserving method, and the ranking of patients based on the estimated probability of malignancy remains the same before and after updating.

    “This method is thus a rank-preserving method, and the ranking of patients based on the estimated probability of malignancy remains the same before and after updating.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable).

    Premisenone given
    § Panel: Defining a decision threshold · p. 3

    The weight of the consequences of using a model to support a decision might vary by the nature and effects of the intervention, the health-care system, or by clinician and patient.

    “The weight of these consequences might vary by the nature and effects of the intervention, the health-care system, or by clinician and patient.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: The primary aim of most predictive AI models in medical practice is to support subsequent decision making.
  • May combine two claims.

    Premisecitation
    § Calibration · p. 6

    ECE, ECI, and ICI depend on the grouping or smoothing methods used and have issues with statistical consistency.

    “Further, ECE, ECI, and ICI depend on the grouping or smoothing methods used and have issues with statistical consistency.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [62] Arrieta-Ibarra, 2022, Metrics of calibration for probabilistic predictions, J Mach Learn Res

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S2 (checkable). May combine two claims.

    Interpretationreasoning
    § Clear focus on statistical or decision-analytical evaluation · p. 2

    It is not appropriate to cite good discrimination and calibration or conclude that a model can be used to aid decisions about ovarian surgery.

    “it is not appropriate to cite, for example, good discrimination and calibration or conclude that a model can be used to aid decisions about ovarian surgery.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation
    § Case study: external validation of a diagnostic model for ovarian cancer · p. 3

    There were 434 women with a malignant tumour (prevalence 49%).

    “There were 434 women with a malignant tumour (prevalence 49%). 32”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [32] Landolfo, 2024, Comparison of the ADNEX and ROMA risk prediction models for the diagnosis of ovarian cancer: a multicentre external validation in patients who underwent surgery, Br J Cancer source

      Not checked in the free run.

  • Classified as probably not a substantial claim.

    Premisenone given
    § Panel: Defining a decision threshold · p. 3

    Often, a threshold is chosen by optimising a statistical measure such as the Youden index.

    “Often, however, a threshold is chosen by optimising a statistical measure such as the Youden index (sensitivity + specificity -1).”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The primary aim of most predictive AI models in medical practice is to support subsequent decision making.
  • May combine two claims.

    Premisecitation
    § Overall performance · p. 6

    Discrimination slope and mean absolute prediction error are improper.

    “discrimination slope and mean absolute prediction error are improper.”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites [26] Buja

      Not checked in the free run.

    • cites [27] Gneiting, 2007, Strictly proper scoring rules, prediction, and estimation, J Am Stat Assoc source

      Not checked in the free run.

    • cites [71] Van Houwelingen, 2012

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based). May combine two claims.

    Premisenone given
    § Discrimination · p. 5

    Although true negatives might be highly irrelevant for selected non-medical applications, such errors are generally important in medical applications.

    “Although true negatives might be highly irrelevant for selected non-medical applications, such errors are generally important in medical applications.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationcitation
    § Discrimination · p. 5

    Although discriminatory ability is essential for predictive AI, AUROC alone cannot be used to identify a model as good or useful.

    “Nevertheless, although discriminatory ability is essential for predictive AI, AUROC alone cannot be used to identify a model as good or useful. 51”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [51] de Hond, 2022, Interpreting area under the receiver operating characteristic curve, Lancet Digit Health source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation
    § Case study: external validation of a diagnostic model for ovarian cancer · p. 3

    Logistic recalibration is similar to Platt scaling, a well known method in machine learning to improve the calibration of predictions.

    “This method is similar to Platt scaling, a well known method in machine learning to improve the calibration of predictions. 34,35”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [34] Ojeda, 2023, Calibrating machine learning approaches for probability estimation: a comprehensive comparison, Stat Med source

      Not checked in the free run.

    • cites [35] Platt, 1999, Probabilistic outputs for support vector machines and comparison to regularized likelihood methods

      Not checked in the free run.

  • May combine two claims.

    Premisecitation
    § Case study: external validation of a diagnostic model for ovarian cancer · p. 3

    The TransIOTA study externally validated ADNEX for its ability to distinguish benign from malignant tumours, using data from 894 women recruited between 2015 and 2019 in one secondary and five tertiary care centres in four countries.

    “The TransIOTA study externally validated ADNEX for its ability to distinguish benign from malignant tumours, using data from 894 women recruited between 2015 and 2019 in one secondary and five tertiary care centres in four countries (Belgium, Italy, Czech Republic, and United Kingdom).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [32] Landolfo, 2024, Comparison of the ADNEX and ROMA risk prediction models for the diagnosis of ovarian cancer: a multicentre external validation in patients who underwent surgery, Br J Cancer source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S4 (based).

    Premisenone given
    § Department of Development · p. 2

    In biomedical applications, the consequences of a false negative are almost always different from the consequences of a false positive.

    “In biomedical applications, the consequences of a false negative (for instance, not referring a woman with ovarian malignancy for advanced surgery) are almost always different from the consequences of a false positive (referring a woman with a benign tumour for advanced surgery).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationreasoning
    § Discrimination · p. 5

    AUPRC and pAUROC mix statistical performance with aspects of clinical utility without following decision-analytical principles.

    “AUPRC and pAUROC mix statistical performance with aspects of clinical utility without following decision-analytical principles.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation
    § Discrimination · p. 4

    For binary outcomes, the C-statistic is equal to area under the receiver operating characteristic curve (AUROC).

    “For binary outcomes, the C-statistic is equal to area under the receiver operating characteristic curve (AUROC). 37,38”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [37] Bradley, 1997, The use of the area under the ROC curve in the evaluation of machine learning algorithms, Pattern Recognit source

      Not checked in the free run.

    • cites [38] Verbakel, 2020, ROC curves for clinical prediction models part 1. ROC plots showed no added value above the AUC when evaluating the performance of clinical prediction models, J Clin Epidemiol source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation
    § Overall performance · p. 6

    Loglikelihood, logloss, and Brier score are strictly proper.

    “Loglikelihood, logloss, and Brier score are strictly proper”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites [26] Buja

      Not checked in the free run.

    • cites [27] Gneiting, 2007, Strictly proper scoring rules, prediction, and estimation, J Am Stat Assoc source

      Not checked in the free run.

    • cites [71] Van Houwelingen, 2012

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation
    § Calibration · p. 5

    Calibration approaches can be classified into three increasingly stringent levels, labelled as mean, weak, and moderate calibration.

    “These approaches can be classified into three increasingly stringent levels, labelled as mean, weak, and moderate calibration. 52”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [52] Van Calster, 2016, A calibration hierarchy for risk models was defined: from utopia to empirical data, J Clin Epidemiol source

      Not checked in the free run.

  • May combine two claims.

    Interpretationcitation
    § Discrimination · p. 4

    AUROC, AUPRC, and pAUROC are semi-proper, because these rank-based measures are invariant to monotonic transformations of probability estimates.

    “AUROC, AUPRC, and pAUROC are semi-proper, because these rank-based measures are invariant to monotonic transformations of probability estimates. 48”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [48] Pepe, 2015, The Net Reclassification Index (NRI): a misleading measure of prediction improvement even with independent test data sets, Stat Biosci source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S4 (based). May combine two claims.

    Premisenone given
    § Panel: Defining a decision threshold · p. 3

    When maximising the Youden index, sensitivity and specificity are considered equally important; this is rarely the case in medicine.

    “When maximising the Youden index, sensitivity and specificity are considered equally important; this is rarely the case in medicine.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: The primary aim of most predictive AI models in medical practice is to support subsequent decision making.
  • Classified as probably not a substantial claim. May combine two claims.

    Premisenone given
    § Clear focus on statistical or decision-analytical evaluation · p. 2

    The first four performance domains focus on different aspects of statistical performance, whereas the clinical utility domain focuses on decision-analytical performance.

    “The fi rst four performance domains (appendix p 2) focus on different aspects of statistical performance, whereas the clinical utility domain focuses on decision-analytical performance.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S2 (checkable).

    Interpretationreasoning
    § Discussion · p. 8

    Improper measures might mislead researchers instead of clarifying the performance of a model.

    “Improper measures might mislead researchers instead of clarifying the performance of a model.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S4 (based). May combine two claims.

    Premisenone given
    § Discussion · p. 9

    Classification accuracy, balanced accuracy, Youden index, DOR, kappa, F1, and MCC are improper at clinically relevant decision thresholds; in addition, some measures are hard to interpret.

    “These measures are improper at clinically relevant decision thresholds; in addition, some measures are hard to interpret.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).

    Premisenone given
    § Discussion · p. 9

    Displaying the distribution of risk estimates for each outcome category provides valuable insights into a model's behaviour.

    “Displaying the distribution of the risk estimates for each outcome category provides valuable insights into a model's behaviour.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationnone given
    § Discussion · p. 8

    F1 is the only measure violating both characteristics: being improper and not having a clear focus on either statistical or decision-analytical performance.

    “Remarkably, F1 is the only measure violating both characteristics.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation
    § Clinical utility · p. 7

    Net benefit and standardised net benefit are semi-proper; the probability estimates below the threshold can be anything as long as they are below the threshold, and the same goes for probability estimates above the threshold.

    “Net benefit and standardised net benefit are semi-proper; the probability estimates below the threshold can be anything as long as they are below the threshold, and the same goes for probability estimates above the threshold.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [48] Pepe, 2015, The Net Reclassification Index (NRI): a misleading measure of prediction improvement even with independent test data sets, Stat Biosci source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisenone given
    § Overall performance · p. 6

    All discussed overall performance measures have a focus on statistical performance.

    “All discussed overall measures have a focus on statistical performance.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable).

    Interpretationreasoning
    § Discussion · p. 9

    Discrimination and calibration aid the modeller and clinician to understand how a model can be improved.

    “Discrimination and calibration aid the modeller and clinician to understand how a model can be improved.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Premisenone given
    § Discussion · p. 9

    ROC and PR curves provide limited additional information over AUROC.

    “These plots provide limited additional information over AUROC.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisenone given
    § Clinical utility · p. 7

    Expected cost is semi-proper because it is insensitive to rank-preserving transformations of the probabilities.

    “Expected cost is semi-proper because it is insensitive to rank-preserving transformations of the probabilities.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation
    § Clinical utility · p. 7

    Standardised net benefit equals net benefit divided by prevalence, and its maximum value is 1.

    “Standardised net benefit equals net benefit divided by prevalence, and its maximum value is 1.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [84] Kerr, 2016, Assessing the clinical impact of risk prediction models with decision curves: guidance for correct interpretation and appropriate use, J Clin Oncol source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation
    § Discussion · p. 9

    Calibration intercept and calibration slope are hard to interpret and provide a partial assessment of calibration; during internal validation, calibration slope can be used to gauge overfitting.

    “These measures are hard to interpret and provide a partial assessment of calibration; during internal validation, calibration slope can be used to gauge overfitting.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [66] Kattan, 2018, The index of prediction accuracy: an intuitive measure useful for evaluating risk prediction models, Diagn Progn Res source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation
    § Classification measures · p. 7

    A limitation of ROC and PR curves is that the thresholds are not easily visible.

    “A limitation of these plots is that the thresholds are not easily visible (figure 1).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [38] Verbakel, 2020, ROC curves for clinical prediction models part 1. ROC plots showed no added value above the AUC when evaluating the performance of clinical prediction models, J Clin Epidemiol source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Premisereasoning
    § Discussion · p. 9

    Sensitivity and specificity are largely theoretical as they condition on the predicted outcome.

    “However, these measures are largely theoretical as they condition on the predicted outcome.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation
    § Clinical utility · p. 7

    Setting misclassification costs is not straightforward, and disagreements can occur about what the costs should be.

    “Setting misclassification costs is not straightforward, and disagreements can occur about what the costs should be (appendix p 13).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [85] Vickers, 2019, A simple, step-by-step guide to interpreting decision curve analysis, Diagn Progn Res source

      Not checked in the free run.

  • May combine two claims.

    Premisenone given
    § Discussion · p. 9

    Discrimination slope and MAPE are improper; values can be better for incorrect models than for the correct model.

    “These measures are improper; ie, values can be better for incorrect models than for the correct model.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.

    Premisenone given
    § Discussion · p. 9

    AUROC quantifies discrimination, which is a key component of statistical model performance.

    “This measure quantifies discrimination, which is a key component of statistical model performance.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation
    § Clinical utility · p. 7

    Net benefit sets the decision threshold based on the misclassification costs, following the classic connection between both.

    “Net benefit sets the decision threshold based on the misclassification costs, following the classic connection between both.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [18] Pauker, 1975, Therapeutic decision making: a cost-benefit analysis, N Engl J Med source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation
    § Clinical utility · p. 7

    Expected cost searches for the decision threshold that minimises cost given the misclassification costs.

    “In contrast to net benefit, expected cost searches for the decision threshold that minimises cost given the misclassification costs.”
    Quote in the paperNot a substantial claim0 of 4 sources checked
    • cites [86] Margineantu, 2000, Bootstrap methods for the cost-sensitive evaluation of classifiers

      Not checked in the free run.

    • cites [87] Ferrer, 2022, Analysis and comparison of classification metrics, arXiv

      Not checked in the free run.

    • cites [88] Provost, 2001, Robust classification for imprecise environments, Mach Learn source

      Not checked in the free run.

    • cites [89] Van Calster, 2015, Calibration of risk prediction models: impact on decision-analytic performance, Med Decis Making source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).

    Interpretationnone given
    § Discussion · p. 9

    Poor discrimination indicates that other predictors facilitating improved distinction between individuals with and without the event could be selected.

    “Poor discrimination indicates that other predictors facilitating improved distinction between individuals with and without the event could be selected.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation
    § Clinical utility · p. 7

    Miscalibration of the model might be reflected in the decision threshold at which expected cost is minimised, whereas net benefit fixes the threshold such that miscalibration reduces the net benefit value.

    “Miscalibration of the model might thus be reflected in the decision threshold at which expected cost is minimised, whereas net benefit fi xes the threshold such that miscalibration reduces the net benefit value.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [89] Van Calster, 2015, Calibration of risk prediction models: impact on decision-analytic performance, Med Decis Making source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S4 (based). May combine two claims.

    Premisenone given
    § Discussion · p. 9

    AUPRC and pAUROC attempt to move beyond a statistical assessment but violate decision-analytical principles.

    “These measures attempt to move beyond a statistical assessment but violate decision-analytical principles.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S4 (based). May combine two claims.

    Premisenone given
    § Discussion · p. 9

    ECI, ICI, and ECE summarise calibration plots, concealing the nature and direction of miscalibration, and struggle with statistical consistency.

    “These measures summarise calibration plots, concealing the nature and direction of miscalibration, and struggle with statistical consistency.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.

    Premisenone given
    § Discussion · p. 9

    The O:E ratio is interpretable but provides only a partial assessment of calibration; it is often 1 or close to 1 during internal validation.

    “This measure is interpretable but provides only a partial assessment of calibration; O:E ratio is often 1 or close to 1 during internal validation.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisereasoning
    § Classification measures · p. 6

    MCC has no intuitive interpretation.

    “Similar to F1, MCC has no intuitive interpretation.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisenone given
    § Discussion · p. 9

    PPV and NPV are highly practical measures because they condition on the classification.

    “PPV and NPV are highly practical measures because they condition on the classification.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Interpretationnone given
    § Discussion · p. 9

    Overall performance measures combine discrimination and calibration performance, making them less informative than separate assessments of discrimination and calibration performance.

    “Overall performance measures combine discrimination and calibration performance, making them less informative than separate assessments of discrimination and calibration performance.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S4 (based). May combine two claims.

    Interpretationnone given
    § Discussion · p. 9

    PPV in combination with NPV, or sensitivity in combination with specificity, are improper when used alone.

    “These measures are improper when used alone.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable). May combine two claims.

    Interpretationnone given
    § Discussion · p. 9

    NB or standardised NB (with a decision curve) and EC (with a cost curve) are important measures to quantify to what extent better decisions are made.

    “NB or standardised NB (with a decision curve) and EC (with a cost curve) Recommended Important measures to quantify to what extent better decisions are made.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable). May combine two claims.

    Interpretationnone given
    § Discussion · p. 10

    Class imbalance is related to the target population as an epidemiological feature of the data, whereas misclassification costs are clinical concepts that relate to the context of decision making.

    “Class imbalance is related to the target population as an epidemiological feature of the data, whereas misclassification costs are clinical concepts that relate to the context of decision making.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).

    Interpretationnone given
    § Discussion · p. 10

    The principles also hold for other types of outcomes, such as nominal, ordinal, time-to-event, or competing risk outcomes.

    “Nevertheless, the principles also hold for other types of outcomes, such as nominal, ordinal, time-to-event, or competing risk outcomes.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Interpretationnone given
    § Discussion · p. 9

    For well-developed models, an O:E ratio close to 1 is expected.

    “we would expect an O:E ratio close to 1 for welldeveloped models.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Interpretationnone given
    § Discussion · p. 10

    Competing models can be evaluated using the same core set of measures and visualisations.

    “Although competing models can be evaluated using the same core set of measures and visualisations, proper overall measures become more interesting for tasks such as model selection and comparison.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S4 (based).

    Interpretationnone given
    § Discussion · p. 9

    Decision curves of NB allow one to show potential clinical utility at various clinically relevant decision thresholds relative to default decisions (and competing models).

    “Decision curves of NB allow one to show potential clinical utility at various clinically relevant decision thresholds relative to default decisions (and competing models).”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Interpretationnone given
    § Discussion · p. 10

    Adequate sample size is important to evaluate performance with sufficient precision.

    “First, adequate sample size is important to evaluate performance with sufficient precision.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation
    § Discussion · p. 10

    Previous recommendations were to include at least 100 to 200 individuals in the smallest outcome category.

    “Previous recommendations were to include at least 100 to 200 individuals in the smallest outcome category.”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [52] Van Calster, 2016, A calibration hierarchy for risk models was defined: from utopia to empirical data, J Clin Epidemiol source

      Not checked in the free run.

    • cites [99] Collins, 2016, Sample size considerations for the external validation of a multivariable prognostic model: a resampling study, Stat Med source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).

    Interpretationcitation
    § Discussion · p. 9

    Miscalibration is often not just a problem of the model but a sign that we need to improve our understanding of the various contexts in which the model is validated and used.

    “Miscalibration is often not just a problem of the model but a sign that we need to improve our understanding of the various contexts in which the model is validated and used.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [91] Van Calster, 2023, There is no such thing as a validated prediction model, BMC Med source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).

    Interpretationnone given
    § Discussion · p. 10

    Proper overall measures become more interesting for tasks such as model selection and comparison.

    “Although competing models can be evaluated using the same core set of measures and visualisations, proper overall measures become more interesting for tasks such as model selection and comparison.”
    Quote in the paperNot a substantial claim
86 of 86
  • The authors state this as an assumption.

    Using a decision threshold of 0.1 for probability of malignancy assumes that the medical benefit of advanced surgery on a malignant tumour is nine times greater than the harm of unnecessary advanced surgery in individuals with a benign tumour.

    “Hence, using this threshold assumes that the medical benefit of advanced surgery on a malignant tumour is nine times greater than the harm of unnecessary advanced surgery in individuals with a benign tumour. 18”
  • The paper relies on this without support.

    The primary aim of most predictive AI models in medical practice is to support subsequent decision making.

    “The primary aim of most predictive AI models in medical practice is to support subsequent decision making.”
  • The authors state this as an assumption.

    The range of reasonable decision thresholds is 0.05 to 0.40 (normalised cost of false negatives between 0.60 and 0.95).

    “We further assume that the range of reasonable thresholds is 0 ⋅ 05 to 0 ⋅ 40 (normalised cost of false negatives between 0 ⋅ 60 and 0 ⋅ 95).”
3 of 3

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • Recalibrated logloss conflicts with loglikelihood

    Minor

    The paper defines logloss as negative loglikelihood. After recalibration, a loglikelihood of −337 therefore implies a logloss of 337, not the reported 377. The reported logloss also falls outside its stated 95% confidence interval of 307 to 368 and would contradict the claim that all strictly proper measures improved.

  • AUPRC confidence-interval upper bound differs between text and table

    Minor

    The text gives an AUPRC 95% confidence-interval upper bound of 0.91, whereas the table gives 0.921, which rounds to 0.92 at the precision used in the text.

2 of 2

Cites

Flagged first, then by citations

Research works printed but not linked: 12

  1. Hernández-Orallo, 2012, A unified view of performance metrics: translating threshold choice of into expected classification loss, J Mach Learn Res, 13, 2813
  2. Riley, 2024, Evaluation of clinical prediction models (part 2): how to undertake an external validation study, BMJ, 384
  3. McDermott, 2024, A closer look at AUROC and AUPRC under class imbalance, Adv Neural Inf Process Syst, 37, 44102
  4. Błasiok, 2023, Smooth ECE: principled reliability diagrams via kernel smoothing, arXiv
  5. Arrieta-Ibarra, 2022, Metrics of calibration for probabilistic predictions, J Mach Learn Res, 23, 1
  6. Vickers, 2016, Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests, BMJ, 352
  7. Ferrer, 2022, Analysis and comparison of classification metrics, arXiv
  8. Wynants, 2020, Prediction models for diagnosis and prognosis of COVID-19: systematic review and critical appraisal, BMJ, 369
  9. Andaur Navarro, 2021, Risk of bias in studies on prediction models developed using supervised machine learning techniques: systematic review, BMJ, 375
  10. Debray, 2023, Transparent reporting of multivariable prediction models developed or validated using clustered data (TRIPOD-Cluster): explanation and elaboration, BMJ, 380
  11. Perez-Lebel, 2022, Beyond calibration: estimating the grouping loss of modern neural networks, arXiv
  12. Gupta, 2020, Evaluation of machine learning algorithms for predicting readmission after acute myocardial infarction using routinely collected clinical data, Can J Cardiol, 36, 878

Cited by

Sorted by citations

Authors
Van Calster, B., Collins, G. S., Vickers, A. J., Wynants, L., Kerr, K. F., Barreñada, L., Varoquaux, G., Singh, K., Moons, K. G., Hernandez-Boussard, T., Timmerman, D., McLernon, D. J., van Smeden, M., & Steyerberg, E. W.
Affiliations
  • Memorial Sloan Kettering Cancer Center (US)
  • Maastricht University (NL)
  • University of Washington (US)
  • KU Leuven (BE)
  • Institut national de recherche en sciences et technologies du numérique (FR)
  • University of California San Diego (US)
  • Utrecht University (NL)
  • University of Aberdeen (GB)
Corresponding author
Steyerberg, Ewout W
Venue
The Lancet Digital Health
Publisher
Elsevier BV
Published
2025-12
Volume
7
Issue
12
Pages
100916
ISSN
2589-7500 (ISSN-L)
OpenAlex
W4417296978
Cited by
112
References
90
Citations by year
2026: 111 · 2025: 1
FWCI
6.62
Type
journal article
Language
en
Open access
Locations
  • The Lancet Digital Health (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (publishedVersion, cc-by)
  • Leiden Repository (Leiden University) (submittedVersion, cc-by)
  • Lirias (submittedVersion, cc-by)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by)
  • HAL (submittedVersion, cc-by)
  • Aberdeen University Research Archive (Aberdeen University) (submittedVersion)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
  • Leiden Repository (Leiden University) (submittedVersion)
Funders
  • National Institutes of Health National Cancer Institute (P30CA008748)
  • Engineering and Physical Sciences Research Council (EP/Y018516/1)
  • National Center for Advancing Translational Sciences (C24/15/037, UL1TR003142, 12F3114N, G0B4716N, G049312N)
  • Foundation for the National Institutes of Health
  • Cancer Research UK (MR/V038168/1, C49297/A27294)
  • Research Foundation Flanders (G097322N)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R42AI177108, ANR-22-PESN-0003, R01 DK093770, R01DK133226, R01EB030492)
  • KU Leuven Research Council
  • National Institute for Health and Care Research
  • National Institutes of Health
  • KU Leuven (C24M/20/064)
  • National Library of Medicine
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek (9150172310023)
  • Fight against Cancer
Topics
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Epidemiology
  • Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
Keywords
performance indicators, clinical decision support, binary outcome prediction, proper scoring rules, calibration, discrimination (statistics), clinical utility, net benefit, decision curve analysis, misclassification cost, ADNEX model, model validation
MeSH terms
Clinical Decision-Making, Artificial Intelligence, Humans

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review